ZNTL · Zentalis Pharmaceuticals, Inc. · Executive Compensation
$2.79
+0.27 (+10.71%)
At close · Oct 5
Return incl. dividend (before tax)
Market Cap
$184.91M
Shares
71.67M
Volume · Oct 5
2.63M
Avg daily vol (3M)
1.18M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Andrea Paul | Former Chief Legal Officer and Corporate Secretary | $2,988,669 |
| Julie Eastland | President and Chief Executive Officer | $1,300,731 |
| Mark Lackner | Former Chief Scientific Officer | $1,229,349 |
| Ingmar Bruns | Chief Medical Officer | $869,843 |
| James Bucher | Chief Legal Officer and Corporate Secretary | $659,973 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Julie Eastland | President and Chief Executive Officer | $8,188,909 |
| Kimberly Blackwell | Former Chief Executive Officer and Interim Chief Medical Officer | $7,466,453 |
| Diana Hausman | Former Chief Medical Officer | $7,063,793 |
| Cam Gallagher | Former President, Interim Chief Financial Officer and Interim Treasurer | $5,819,024 |
| Mark Lackner | Former Chief Scientific Officer | $4,788,822 |
| Andrea Paul | Chief Legal Officer and Corporate Secretary | $3,678,975 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Kimberly Blackwell | Former Chief Executive Officer and Interim Chief Medical Officer | $12,853,590 |
| Cam Gallagher | Former President, Interim Chief Financial Officer and Interim Treasurer | $8,581,060 |
| Iris Roth | Former Chief Operating Officer | $5,931,787 |
| Melissa Epperly | Former Chief Financial Officer and Treasurer | $5,631,323 |
| Kevin Bunker | Former Chief Scientific Officer | $5,115,956 |
| Andrea Paul | Chief Legal Officer and Corporate Secretary | $2,629,027 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Kimberly Blackwell | Chief Executive Officer | $36,614,376 |
| Cam Gallagher | President, Interim Chief Financial Officer and Interim Treasurer | $10,629,545 |
| Anthony Sun | Former President and Chief Executive Officer | $9,098,448 |
| Carrie Brownstein | Chief Medical Officer | $8,830,657 |
| Andrea Paul | Chief Legal Officer and Corporate Secretary | $6,214,856 |
| Kevin Bunker | Former Chief Scientific Officer | $5,722,062 |
| Melissa Epperly | Former Chief Financial Officer and Treasurer | $4,026,248 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Anthony Sun | Former President and Chief Executive Officer | $5,935,085 |
| Kevin Bunker | Former Chief Scientific Officer | $2,806,833 |
| Melissa Epperly | Former Chief Financial Officer and Treasurer | $2,336,683 |
| Dimitris Voliotis | SVP, Clinical Development | $1,382,546 |
| Alexis M. Pinto | Chief Legal Officer | $1,315,850 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Anthony Sun | Former President and Chief Executive Officer | $15,044,399 |
| Alexis M. Pinto | Chief Legal Officer | $6,533,902 |
| Kevin Bunker | Chief Scientific Officer | $6,273,594 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Anthony Sun | President and Chief Executive Officer | $1,577,882 |
| Kevin Bunker | Chief Operating Officer | $779,434 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Shannon Campbell | Class I director | Appointed | 2026-05-27 |
| Karan Takhar | member of the Board of Directors | Resigned | 2025-12-15 |
| James B. Bucher | Chief Legal Officer and Corporate Secretary | Appointed | 2025-08-26 |
| Andrea Paul | Chief Legal Officer and Corporate Secretary | Resigned | 2025-08-26 |
| Cam Gallagher | member of the Board | Resigned | 2024-11-13 |
| Vincent Vultaggio | interim principal financial officer | Appointed | 2024-11-13 |
| Scott Myers | Class II director | Appointed | 2024-11-13 |
| Cam Gallagher | President | Resigned | 2024-11-13 |
| Cam Gallagher | Interim Chief Financial Officer | Resigned | 2024-11-13 |
| Kimberly Blackwell | member of the Board | Resigned | 2024-11-13 |
| Scott Myers | Chairperson of the Board | Appointed | 2024-11-13 |
| Julie Eastland | President | Appointed | 2024-11-13 |
| Julie Eastland | Class I director | Appointed | 2024-11-13 |
| Kimberly Blackwell | Chief Executive Officer | Resigned | 2024-11-13 |
| Julie Eastland | Chief Executive Officer | Appointed | 2024-11-13 |
| Luke Walker, M.D. | Class II director | Appointed | 2024-05-29 |
| Vincent Vultaggio | interim principal accounting officer | Appointed | 2024-04-11 |
| Cam Gallagher | interim Chief Financial Officer, Treasurer and principal financial officer | Appointed | 2024-04-11 |
| Melissa Epperly | Chief Financial Officer, Treasurer, principal financial officer and principal accounting officer | Resigned | 2024-04-11 |
| Carrie Brownstein, M.D. | Chief Medical Officer | Resigned | 2024-01-25 |
| Diana Hausman, M.D. | member of the Board of Directors | Resigned | 2024-01-25 |
| Diana Hausman, M.D. | Chief Medical Officer | Appointed | 2024-01-25 |
| Iris Roth | Chief Operating Officer | Appointed | 2023-02-13 |
| Kevin Bunker | Chief Scientific Officer | Appointed | 2022-09-27 |
| Jan Skvarka, Ph.D., M.B.A. | Class III director | Appointed | 2022-09-12 |